UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

The New England journal of medicine, 2008-02, Vol.358 (6), p.580-591

2008

Volltextzugriff (PDF)

Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study

Diabetologia, 2018-08, Vol.61 (8), p.1724-1733

2018

Volltextzugriff (PDF)

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

Diabetes, obesity & metabolism, 2019-05, Vol.21 (5), p.1199-1208

2019

Volltextzugriff (PDF)

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

The New England journal of medicine, 2013-12, Vol.369 (26), p.2492-2503

2013

Volltextzugriff (PDF)

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

The Lancet (British edition), 2010-11, Vol.376 (9752), p.1543-1551

2010

Volltextzugriff (PDF)

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

The New England journal of medicine, 2012-12, Vol.367 (23), p.2204-2213

2012

Volltextzugriff (PDF)

Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes

Diabetic medicine, 2021-05, Vol.38 (5), p.e14459-n/a

2021

Volltextzugriff (PDF)

Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

Diabetes, obesity & metabolism, 2018-06, Vol.20 (6), p.1369-1376

2018

Volltextzugriff (PDF)

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study

Diabetologia, 2019-09, Vol.62 (9), p.1575-1580

2019

Volltextzugriff (PDF)

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

The New England journal of medicine, 2009-11, Vol.361 (21), p.2019-2032

2009

Volltextzugriff (PDF)

Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers

Kidney international, 2012-08, Vol.82 (3), p.330-337

2012

Volltextzugriff (PDF)

Microalbuminuria as an early marker for cardiovascular disease

Journal of the American Society of Nephrology, 2006-08, Vol.17 (8), p.2100-2105

2006

Volltextzugriff (PDF)

Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria

Diabetologia, 2020-12, Vol.63 (12), p.2713-2724

2020

Volltextzugriff (PDF)

Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes

Diabetes care, 2011-05, Vol.34 (5), p.1081-1085

2011

Volltextzugriff (PDF)

Vitamin D Levels and Mortality in Type 2 Diabetes

Diabetes care, 2010-10, Vol.33 (10), p.2238-2243

2010

Volltextzugriff (PDF)

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial

Diabetes, obesity & metabolism, 2022-02, Vol.24 (2), p.257-267

2022

Volltextzugriff (PDF)

The renal protective effect of angiotensin receptor blockers depends on intra‐individual response variation in multiple risk markers

British journal of clinical pharmacology, 2015-10, Vol.80 (4), p.678-686

2015

Volltextzugriff (PDF)

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria

PloS one, 2021-03, Vol.16 (3), p.e0244402-e0244402

2021

Volltextzugriff (PDF)

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study

PloS one, 2018-04, Vol.13 (4), p.e0196634-e0196634

2018

Volltextzugriff (PDF)

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e017462-e017462

2020

Volltextzugriff (PDF)

Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuria

Journal of diabetes and its complications, 2024-06, Vol.38 (6), p.108765, Article 108765

2024

Volltextzugriff (PDF)

Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort

Diabetologia, 2018-01, Vol.61 (1), p.231-241

2018

Volltextzugriff (PDF)

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: A randomized double-blind crossover trial

Diabetes care, 2003-08, Vol.26 (8), p.2268-2274

2003

Volltextzugriff (PDF)

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study

Diabetologia, 2019-01, Vol.62 (1), p.147-155

2019

Volltextzugriff (PDF)

1 – 25 von 540

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(506)
Mit Volltextzugriff
(447)

Publikationsform

Artikel
(539)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(406)
Science & Technology
(384)
Life Sciences & Biomedicine
(379)
Male
(294)
Female
(292)
Middle Aged
(238)
Biological And Medical Sciences
(209)
Medical Sciences
(208)
Adult
(183)
Diabetes
(174)
Endocrinopathies
(144)
Diabetes. Impaired Glucose Tolerance
(143)
Endocrine Pancreas. Apud Cells
(143)
Endocrinology & Metabolism
(141)
Aged
(132)
Risk Factors
(116)
Urology & Nephrology
(114)
Glomerular Filtration Rate
(113)
Diabetes Mellitus, Type 2 - Complications
(94)
Diabetic Nephropathies - Drug Therapy
(94)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes

Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers

Microalbuminuria as an early marker for cardiovascular disease

Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria

Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia

Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes

Vitamin D Levels and Mortality in Type 2 Diabetes

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial

The renal protective effect of angiotensin receptor blockers depends on intra‐individual response variation in multiple risk markers

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuria

Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: A randomized double-blind crossover trial

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study

Suchergebnisse filtern